GMP cleanroom requirements for pharmaceutical industry

GMP cleanrooms in the pharmaceutical industry are controlled environments designed to minimize the risk of contamination during manufacturing processes. Their requirements are defined primarily in EU GMP Annex 1 and supported by ISO 14644 standards for airborne particle classification.
Cleanroom compliance is based on maintaining defined environmental conditions both “at rest” and “in operation”, ensuring consistent product quality and patient safety.

GMP vs ISO 14644

ISO 14644-1 classifies cleanrooms based on the concentration of airborne particles per cubic meter of air.

EU GMP Annex 1 builds on this by introducing requirements for:

Microbiological (viable) contamination
Environmental monitoring
Process protection
Contamination control strategy (CCS)

ISO classification alone is not sufficient for pharmaceutical applications; GMP compliance requires control of both non-viable and viable contamination.

GMP cleanroom classification

EU GMP Annex 1 defines four cleanroom grades:

Grade A (ISO 5): critical aseptic operations
Grade B: background environment for Grade A
Grade C: less critical steps
Grade D: initial stages

Limits apply to both “at rest” and “in operation” conditions, with stricter requirements during operation.

Environmental and airflow requirements

GMP requires controlled airflow patterns and pressure differentials to prevent contamination.

Grade A zones use unidirectional airflow
Grades B–D typically use mixed airflow systems
Pressure differentials (typically ≥10 Pa) ensure airflow from cleaner to less clean areas

Air handling systems must include HEPA filtration and provide sufficient air changes to maintain classification under operational conditions.

Contamination Control Strategy (CCS)

EU GMP Annex 1 requires the implementation of a documented Contamination Control Strategy (CCS) that addresses all potential sources of contamination. This strategy encompasses key elements such as facility and HVAC design, personnel and material flows, cleaning and disinfection procedures, and environmental monitoring. By integrating these aspects, the CCS provides a structured, lifecycle-based approach to effectively manage and control contamination risks.

Validation and monitoring

Qualification stages

Cleanrooms must be qualified and continuously monitored to demonstrate compliance.

DQ (Design Qualification) - Verifies that the cleanroom design meets GMP and user requirements.
IQ (Installation Qualification) - Confirms that systems (HVAC, panels, filters, equipment) are installed according to specifications.
OQ (Operational Qualification) - Verifies that systems operate within defined limits (airflow, pressure, temperature, alarms).
PQ (Performance Qualification) - Demonstrates that the cleanroom performs as intended under real operational conditions.

Monitoring & data integrity

Ongoing monitoring includes:

Airborne particle counting
Microbiological monitoring
Pressure and airflow verification

For GMP environments, data integrity is critical. Systems used for monitoring and data management must comply with 21 CFR Part 11, ensuring:

Secure data storage
Audit trails
Electronic record integrity

ABN Cleanroom Technology’s GMP Connect platform is designed in accordance with these requirements, enabling compliant monitoring and data handling within regulated environments.

Process flow and cleanroom operation

GMP cleanrooms must be designed around controlled processes and personnel flows.
Personnel and materials typically move progressively from: Grade D -> Grade C -> Grade B -> Grade A

To maintain this flow:

Personnel Airlocks (PAL) and Material Airlocks (MAL) are required
In higher-risk environments, double PAL/MAL configurations are implemented
Gowning procedures follow stepwise transitions aligned with cleanroom grades

These controlled pathways are essential to prevent cross-contamination and maintain environmental integrity.

Typical applications

For hospital environments, ABN Cleanroom Technology has developed the SteriCube HOSPIX solution: a mobile modular cleanroom concept specifically designed for pharmaceutical departments preparing cytostatic medicines, ensuring compliance with GMP requirements while enabling efficient integration within hospital infrastructure.

Design consideration

Design for compliance

EU GMP Annex 1 requires that cleanrooms are designed to minimize contamination risks and support validation and monitoring. At ABN Cleanroom Technology, cleanrooms are configured using pre-engineered and validated building blocks within a Configure-to-Order Plus (CTO+) methodology.

This approach ensures that:

Compliance is embedded in the design phase
Critical parameters are predefined and validated
Cleanrooms meet regulatory requirements from the outset

Design for operational reality

Cleanroom performance must be maintained under real conditions. Personnel movement, equipment layout and material flow directly influence contamination behaviour.
Improper airflow distribution, poor zoning or inadequate return placement can lead to localized contamination risks, even when classification limits are met.

Final thoughts

GMP cleanroom requirements combine ISO-based air cleanliness with regulatory expectations for process control, monitoring and data integrity.
Compliance depends on a cleanroom’s ability to perform consistently under operational conditions, supported by validated design, controlled process flows and continuous monitoring. A design approach that integrates compliance from the outset ensures predictable performance and long-term regulatory alignment.